AI Article Synopsis
- The study examines the trends in blood transfusion and therapeutic plasma exchange (TPE) practices for kidney transplant (KT) patients in South Korea from 2002 to 2017.
- Over this period, the total units of red blood cells (RBCs), platelets, and fresh frozen plasma (FFP) used in KT increased significantly, while the average RBCs transfused per patient decreased.
- The rise in TPE procedures and blood product usage highlights the need for better management and preparation of blood for patients undergoing kidney transplantation, particularly those facing acute rejection.
Article Abstract
Background: The frequency of kidney transplantation (KT) is increasing. Blood transfusion plays an important role in the success of KT. Therapeutic plasma exchange (TPE) is also used for desensitisation in ABO-incompatible KT and treatment of antibody-mediated rejection.
Materials And Methods: We analysed red blood cell (RBC), platelet, and fresh frozen plasma (FFP) usage and the number of TPE procedures performed during the hospitalisation of KT patients from 2002 to 2017 using the Korean National Health Insurance Service-National Health Information Database.
Results: A total of 18,331 KT patients were included in this study. The number of transfused RBCs continued to increase from 4,806 units in 2002-2005 to 12,390 units in 2014-2017. However, the average number of RBCs transfused per patient decreased from 2.17 to 1.79 units. Estimated platelet usage increased from 4,259 units in 2002-2005 to 11,519 units in 2014-2017, and the proportion of filtered platelets increased from 72.6% to 83.4% during the same period. There was a huge increase in the total number of FFP units used, from 2,255 units in 2002-2005 to 51,531 units in 2014-2017. The number of TPE procedures performed also increased from 296 to 6,479 during the same period. Patients with acute rejection accounted for 8.8% of all KT patients, and more RBC and FFP were used for these patients and a greater number of TPE procedures were performed compared to those who did not experience rejection.
Discussion: Blood usage and TPE have increased steadily with the increasing numbers of KTs. Therefore, continuous efforts are needed to ensure appropriate perioperative blood preparation and usage for KT patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925219 | PMC |
| http://dx.doi.org/10.2450/2020.0050-20 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.
J Pathol
December 2024
Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland.
Tumour content plays a pivotal role in directing the bioinformatic analysis of molecular profiles such as copy number variation (CNV). In clinical application, tumour purity estimation (TPE) is achieved either through visual pathological review [conventional pathology (CP)] or the deconvolution of molecular data. While CP provides a direct measurement, it demonstrates modest reproducibility and lacks standardisation.
View Article and Find Full Text PDFThe impact of constipation on lower urinary tract function and treatment response in patients with non-monosymptomatic enuresis.
BMC Urol
December 2024
Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, 16F, #289, Chienkuo Road, Xindian, New Taipei, 23142, Taiwan.
Purpose: The purpose of this study was to compare the differences in lower urinary tract function and treatment response between non-monosymptomatic nocturnal enuresis (NMNE) pediatric patients with and without constipation.
Method: We retrospectively analyzed pediatric patients diagnosed as NMNE from our enuresis database. Inclusion criteria were children aged 5 years or older with a follow-up duration of at least one month.
Metastasis Detection Using True and Artificial T1-Weighted Postcontrast Images in Brain MRI.
Invest Radiol
November 2024
From the Department of Diagnostic and Interventional Neuroradiology, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany (R.H., E.K., Z.B., D.P., R.C., A.R., K.D.); Institute of Applied Mathematics, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany (T.P., A.E.); Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.P.); Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (D.P., H.-P.S.); Department of Diagnostic and Interventional Radiology With Nuclear Medicine, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany (M.F.-D., K.S., G.H., C.P.H.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.F.-D.); Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany (V.W., C.P.H.); Translational Lung Research Center Heidelberg, Member of the German Center of Lung Research (DZL), Heidelberg, Germany (C.P.H.); Praxisnetz, Radiology and Nuclear Medicine, Bonn, Germany (M.V.); Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany (J.A.L.); Chair of Civil Law, Data Protection Law, Law of Data Economy, Digitalization and AI Law, Faculty of Law, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany (L.S.-R.); and German Center for Neurodegenerative Diseases (DZNE), Helmholtz Association of German Research Centers, Venusberg-Campus 1, Bonn, Germany (A.R., K.D.).
Objectives: Small lesions are the limiting factor for reducing gadolinium-based contrast agents in brain magnetic resonance imaging (MRI). The purpose of this study was to compare the sensitivity and precision in metastasis detection on true contrast-enhanced T1-weighted (T1w) images and artificial images synthesized by a deep learning method using low-dose images.
Materials And Methods: In this prospective, multicenter study (5 centers, 12 scanners), 917 participants underwent brain MRI between October 2021 and March 2023 including T1w low-dose (0.
The safety and efficacy of regional citrate anticoagulation for multiple consecutive therapeutic plasma exchanges with fresh frozen plasma as a replacement solution.
Int Urol Nephrol
December 2024
The Department of Nephrology, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Road, Xi'an, 710032, Shaanxi, China.
Background: Therapeutic plasma exchange (TPE) is an important blood purification technology and most patients require multiple consecutive TPEs. Regional citrate anticoagulation (RCA) could be used for membrane therapeutic plasma exchange (mTPE). However, there is no research on the metabolic complications of the RCA for patients receiving multiple consecutive mTPEs with fresh frozen plasma (FFP) as a replacement solution.
View Article and Find Full Text PDFComparing cryoprecipitate-poor plasma to fresh frozen plasma as replacement therapy in thrombotic thrombocytopenic purpura: An updated meta-analysis.
Transfus Apher Sci
November 2024
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile. Electronic address:
Background: Cryoprecipitate-poor plasma (CPP) has been suggested as a promising alternative to the standard fresh frozen plasma (FFP) in plasma exchange therapy (TPE) for thrombotic thrombocytopenic purpura (TTP) given its lower concentrations of von Willebrand Factor (VWF). However, its efficacy and safety remain a topic of debate.
Study Design And Methods: We conducted a systematic review and meta-analysis comparing CPP to FFP during TPE in patients with TTP.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!